An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

This week, the Henry B. Gonzalez Convention Center is where leading doctors from all over have gathered to share research and ...

While speaking on her podcast Tea Time with Raven & Miranda, which she co-hosts with wife Miranda Pearman-Maday, the Disney ...

Raven-Symoné recalled having her first breast reduction when she was just 15 years old. While speaking on her podcast Tea ...

Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

Jaguar Health (JAGX)family company Napo Pharmaceuticals provided an overview of the data from the poster presentation conducted yesterday, ...

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The median time from breast cancer diagnosis to surgery was 0.8 years for risk-reducing mastectomies and three years for risk ...

Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...